ArticlePloS one2013

Discovery of a novel dual fungal CYP51/human 5-lipoxygenase inhibitor: implications for anti-fungal therapy.

Eric K Hoobler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.